Protective effects of phosphodiesterase inhibitors on lung function and remodeling in a murine model of chronic asthma

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 2, 2006, Pages 283-287

  Campos, H S ^a   Xisto, D G ^a   Oliveira, M B G ^a   Teixeira, I ^a   Negri, E M ^b   Mauad, T ^b   Carnielli, D ^b   Lima, L M ^a   Barreiro, E J ^a   Faffe, D S ^a   Zin, W A ^a   Lapa e Silva, J R ^a   Rocco, P R M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Asthma; BALB c mice; Lung function; Phosphodiesterase inhibitors; Steroid

Indexed keywords

ANTIASTHMATIC AGENT; COLLAGEN; DEXAMETHASONE; LASSBIO 596; OVALBUMIN; PHOSPHODIESTERASE IV INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; UNCLASSIFIED DRUG;

AIRWAY RESISTANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHOSPASM; CELL INFILTRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ELASTIC FIBER; EOSINOPHIL; HISTOPATHOLOGY; LUNG COLLAPSE; LUNG FUNCTION; LUNG PARENCHYMA; MORPHOMETRICS; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; QUANTITATIVE ANALYSIS; RANDOMIZATION; VISCOELASTICITY;

ANIMALIA; MURINAE;

EID: 33646249634     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000200016     Document Type: Article

References (18)

1. Tulic MK & Hamid Q (2003). Contribution of the distall lung to the pathologic and physiologic changes in asthma: potential therapeutic target. Roger S. Mitchell lecture. Chest, 123 (Suppl): 348-355.
2. Bousquet J, Jeffery PK, Busse WW et al. (2000). Asthma from bronchoconstriction to airway inflammation and remodeling. American Journal of Respiratory and Critical Care Medicine, 161: 1720-1745.
3. Kumar RK, Herbert C, Thomas PS et al. (2003). Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. Journal of Pharmacology and Experimental Therapeutics, 307: 349-355.
4. Kohyama T, Liu X, Wen FQ et al. (2002). PDE 4 inhibitors attenuate fibroblast chemotaxis and contraction of native collagen gels. American Journal of Respiratory Cell and Molecular Biology, 26: 694-701.
5. Lima LM, Castro P, Machado AL et al. (2002). Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues. Bioorganic and Medicinal Chemistry, 10: 3067-3073.
6. Rocco PR, Momesso DP, Figueira RC et al. (2003). Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury. European Respiratory Journal, 22: 20-27.
7. Essayan DM (2001). Cyclic nucleotide phosphodiesterases. Journal of Allergy and Clinical Immunology, 108: 671-680.
8. Bates JHT, Rossi A & Milic-Emili J (1985). Analysis of the behavior of the respiratory system with constant inspiratory flow. Journal of Applied Physiology, 58: 1840-1848.
9. Weibel ER (1990). Morphometry: stereological theory and practical methods. In: Gil J (Editor), Models of Lung Disease - Microscopy and Structural Methods. Marcel Dekker, New York.
10. Montes GS (1996). Structural biology of the fibres of the collagenous and elastic systems. Cell Biology International, 20: 15-27.
11. Weigert C (1898). Über eine Methode zur Farbung elastischer Fasem. Zentralblatt für Allgemeine Pathologie, und Pathologische Anatomie, 9: 289-292.
12. Blyth DJ, Wharton TF, Pedrick MS et al. (2000). Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody. American Journal of Respiratoty Cell and Molecular Biology, 23: 241-246.
13. Xisto DG, Farias LL, Ferreira HC et al. (2005). Lung parenchyma remodeling in a murine model of chronic allergic inflammation. American Journal of Respiratory and Critical Care Medicine, 171: 829-837.
14. Cortijo J, Bou J, Beleta J et al. (1993). Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus. British Journal of Pharmacology, 108: 562-568.
15. Bundschuh DS, Eltze M, Barsig J et al. (2001). In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. Journal of Pharmacology and Experimental Therapeutics, 297: 280-290.
16. Ichinose F, Erana-Garcia J, Hromi J et al. (2000). Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension. Critical Care Medicine, 29: 1000-1005.
17. Toward TJ, Smith N & Broadley KJ (2004). Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways disease. American Journal of Respiratory and Critical Care Medicine, 169:227-234.
18. Fuhrmann M, Jahn HU, Seybold J et al. (1999). Identification and function of cyclic nucleotide phosphodiesterase isoenzymes in airway epithelial cells. American Journal of Respiratory Cell and Molecular Biology, 20: 292-302.